"We believe the whole trajectory of earnings for TSLA remains too high and could face negative revisions post 1Q25 results," ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Diversified Energy (NYSE:DEC) with a Outperform ...

Suburban Propane Partners (NYSE:SPH) -1.4% in Tuesday's trading but still up 11% YTD as Mizuho maintains an Underperform ...

Amylyx Pharma (AMLX) stock was upgraded to Outperform at Mizuho citing its lead asset avexitide's potential against a rare ...

Mizuho analyst Ann Hynes lowered the firm’s price target on Medpace (MEDP) to $355 from $400 and keeps an Outperform rating on the shares. The ...

Mizuho analyst Ann Hynes raised the firm’s price target on UnitedHealth (UNH) to $650 from $600 and keeps an Outperform rating on the shares.

A Mizuho Americas Services LLC director can pursue discrimination claims alleging she was denied accommodation and unlawfully ...

Equinix (NASDAQ:EQIX – Free Report) had its price objective cut by Mizuho from $1,094.00 to $1,053.00 in a research report ...

Investing.com -- Mizuho analysts cut their price targets on Tesla (NASDAQ:TSLA) and Rivian (NASDAQ:RIVN) shares, attributing the revision to uncertainties around tariffs and regulatory changes ...

Universal bank in EMEA is still a work in progress, but Mizuho has chosen now to hire an M&A banker from BNP Paribas to lead the next stage of growth ...

Imprint, the leading provider of modern co-branded credit cards, today announced the closing of a $500 million warehouse ...

NETSTREIT (NYSE:NTST – Free Report) had its price target lifted by Mizuho from $15.00 to $17.00 in a report published on ...